check_circleStudy Completed
Multiple Sclerosis, Relapsing-Remitting
Bayer Identifier:
14838
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Real-World Betaseron Health Economic Outcomes Study for relapsing forms of multiple sclerosis
Trial purpose
A Web based real world observational study in Relapsing-Remitting Multiple Sclerosis (RRMS) population capturing outcomes reported by patients and by the physicians during 12 months after initiating or resuming Betaseron.
Key Participants Requirements
Sex
BothAge
18 - 65 YearsTrial summary
Enrollment Goal
226Trial Dates
July 2007 - September 2009Phase
N/ACould I Receive a placebo
NoProducts
Betaseron (Interferon beta-1b, BAY86-5046)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States | |
Completed | Many Locations, United States |
Primary Outcome
- Key Objective: To collect patient reported outcomes and clinical assessments via the same web-based data capture tool in a real world setting in relapse-remitting multiple sclerosis patientsdate_rangeTime Frame:Baseline, 1 to12 month outcome questionnairesenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A